Finemark National Bank & Trust / ABBV
Finemark National Bank & Trust’s Abbvie Inc Position
Does Finemark National Bank & Trust own Abbvie Inc (ABBV)? Yes — 81.4K shares worth $19M (+0.58% of its 13F portfolio) as of Q4 2025, up from 79.0K shares the prior filed quarter.
Position Value
$19M
Q4 2025
Shares
81.4K
% of Portfolio
+0.58%
Quarters Held
29
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 81.4K | $19M | +0.58% |
| Q3 2025 | 79.0K | $18M | +0.60% |
| Q2 2025 | 81.0K | $15M | +0.51% |
| Q1 2025 | 80.9K | $17M | +0.62% |
| Q4 2024 | 94.6K | $17M | +0.59% |
| Q3 2024 | 96.7K | $19M | +0.66% |
| Q2 2024 | 95.5K | $16M | +0.60% |
| Q1 2024 | 93.9K | $17M | +0.64% |
| Q4 2023 | 91.7K | $14M | +0.58% |
| Q3 2023 | 93.8K | $14M | +0.61% |
| Q2 2023 | 82.2K | $11M | +0.46% |
| Q1 2023 | 77.6K | $12M | +0.53% |
| Q4 2022 | 44.6K | $7M | +0.32% |
| Q3 2022 | 44.7K | $6M | +0.29% |
| Q2 2022 | 44.5K | $7M | +0.30% |
| Q1 2022 | 45.4K | $7M | +0.29% |
| Q4 2021 | 45.9K | $6M | +0.24% |
| Q3 2021 | 46.8K | $5M | +0.21% |
| Q2 2021 | 44.1K | $5M | +0.20% |
| Q1 2021 | 45.2K | $5M | +0.21% |
| Q4 2020 | 43.6K | $5M | +0.21% |
| Q3 2020 | 40.6K | $4M | +0.17% |
| Q2 2020 | 39.7K | $4M | +0.22% |
| Q1 2020 | 39.3K | $3M | +0.19% |
| Q4 2019 | 38.8K | $3M | +0.17% |
| Q3 2019 | 39.5K | $3M | +0.16% |
| Q2 2019 | 38.5K | $3M | +0.16% |
| Q1 2019 | 31.5K | $3M | +0.15% |
| Q4 2018 | 37.5K | $3M | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Finemark National Bank & Trust’s full portfolio or all institutional holders of ABBV.